DK376386A - Anvendelse af immunglobuliner - Google Patents

Anvendelse af immunglobuliner Download PDF

Info

Publication number
DK376386A
DK376386A DK376386A DK376386A DK376386A DK 376386 A DK376386 A DK 376386A DK 376386 A DK376386 A DK 376386A DK 376386 A DK376386 A DK 376386A DK 376386 A DK376386 A DK 376386A
Authority
DK
Denmark
Prior art keywords
immunglobulines
disease
venously
crohn
polyvalent
Prior art date
Application number
DK376386A
Other languages
English (en)
Other versions
DK376386D0 (da
Inventor
Alfred Haessig
Original Assignee
Schweiz Rotes Kreuz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10583453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK376386(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schweiz Rotes Kreuz filed Critical Schweiz Rotes Kreuz
Publication of DK376386D0 publication Critical patent/DK376386D0/da
Publication of DK376386A publication Critical patent/DK376386A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK376386A 1985-08-07 1986-08-06 Anvendelse af immunglobuliner DK376386A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519848A GB8519848D0 (en) 1985-08-07 1985-08-07 Treatment of chronic inflammatory disease

Publications (2)

Publication Number Publication Date
DK376386D0 DK376386D0 (da) 1986-08-06
DK376386A true DK376386A (da) 1987-02-08

Family

ID=10583453

Family Applications (1)

Application Number Title Priority Date Filing Date
DK376386A DK376386A (da) 1985-08-07 1986-08-06 Anvendelse af immunglobuliner

Country Status (10)

Country Link
US (1) US4676982A (da)
EP (1) EP0213072B1 (da)
JP (1) JPS6253931A (da)
AT (1) ATE63463T1 (da)
AU (1) AU599037B2 (da)
DE (1) DE3679255D1 (da)
DK (1) DK376386A (da)
GB (1) GB8519848D0 (da)
PH (1) PH21275A (da)
ZA (1) ZA865950B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2123338C1 (ru) * 1990-06-15 1998-12-20 Сайтел Корпорейшн Фармацевтическая композиция на основе медиатора межклеточной адгезии (варианты), способ ингибирования межклеточной адгезии, способ лечения воспалительного заболевания, способ анализа тестируемого соединения на способность ингибировать клеточную адгезию, способ получения соединения
CA2148907C (en) * 1992-12-29 2008-07-08 Rebecca H. R. Ward Treatment of inflammatory bowel disease with ifn-gamma inhibitors
US6395273B1 (en) 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
US6767564B2 (en) * 2000-09-02 2004-07-27 The Trustees Of The University Of Pennsylvania Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases
RU2215546C1 (ru) * 2002-03-29 2003-11-10 Алтайский государственный медицинский университет Способ лечения неспецифического язвенного колита

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH392780A (de) * 1961-12-07 1965-05-31 Schweiz Rotes Kreuz Verfahren zur Herstellung von intravenös anwendbaren Antikörperpräparaten humanen Ursprungs
JPS5296731A (en) * 1976-02-05 1977-08-13 Green Cross Corp:The Prophylactics and remedies of cyanomycosis
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
DK166763B1 (da) * 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
CA1260828A (en) * 1983-07-04 1989-09-26 Masakazu Iwai Therapeutic and prophylactic agent for gastrointestinal ulcers
DE3340487A1 (de) * 1983-11-09 1985-05-15 Sandoz-Patent-GmbH, 7850 Lörrach Neue therapeutische verwendung

Also Published As

Publication number Publication date
EP0213072A3 (en) 1987-09-30
AU6089086A (en) 1987-02-12
DK376386D0 (da) 1986-08-06
PH21275A (en) 1987-09-28
EP0213072A2 (en) 1987-03-04
ZA865950B (en) 1988-03-30
DE3679255D1 (de) 1991-06-20
AU599037B2 (en) 1990-07-12
ATE63463T1 (de) 1991-06-15
JPS6253931A (ja) 1987-03-09
US4676982A (en) 1987-06-30
EP0213072B1 (en) 1991-05-15
GB8519848D0 (en) 1985-09-11

Similar Documents

Publication Publication Date Title
FR2551348B1 (fr) Dispositif de perfusion
BR8207836A (pt) Amornador de fluido intravenoso
DE69007881D1 (de) Katheter mit Nadeldichtung.
FR2510892B1 (fr) Seringue
DK0398676T3 (da) Kateter med returstrømsbegrænsning
IT8420419A0 (it) Perfezionamenti apportati al controllo di procedimenti di saldatura ad attrito e ad inerzia.
EP0029063A4 (en) DETERMINATION OF THE NON-A, NON-B HEPATITIS ANTIGENS.
DE3778124D1 (de) Durchflussregeleinrichtung.
ATE15860T1 (de) Automatische injektionsspritze.
DK42782A (da) Anvendelse af emulsionspolymerisater som eneste bindemiddel ipapirstrygemasser
MX18879A (es) Analogos de la prostaglandina de amida heterociclica substituida con 7-oxabicicloheptilo.
DK159219C (da) Kobling til styring af en indstillingsindretnings bevaegelse, navnlig en patientstols
SE7900136L (sv) Flytbarhetshjelpmedel
DK158496C (da) Middel til behandling af saar
BE888224A (fr) Dispositif de preparation et de projection de mortiers de crepissage,
DK376386D0 (da) Anvendelse af immunglobuliner
ES268796Y (es) Disposicion de ojete.
FR2500102B1 (fr) Dispositif d'etancheite
FI812503A7 (fi) Laskimokatetri.
DE3789189D1 (de) Flüssigkeitssteuerung und gedämpfter Flüssigkeitsweg.
DE3377401D1 (de) Non-a, non-b hepatitis antigen
DK570581A (da) Apparat til omroering af slam
FI811797A7 (fi) Suonensisäinen väline.
ES268256Y (es) Dispositivo de cierre con cursor para prendas y analogos.
IT7830790A0 (it) Reagenti per la rivelazione dell'antigene-e e anticorpo-e di epatite b.

Legal Events

Date Code Title Description
A0 Application filed
AHS Application shelved for other reasons than non-payment